Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands (Q37885284)

24 August 2017

1 reference

title

Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands (English)

1 reference

24 August 2017

0 references

1 reference

Javier G Casado

5

0 references

Raquel Tarazona

object named as

Raquel Tarazona

10

0 references

Rafael Solana

object named as

Rafael Solana

9

0 references

author name string

Beatriz Sanchez-Correa

1

1 reference

24 August 2017

Sara Morgado

2

1 reference

24 August 2017

Inmaculada Gayoso

3

1 reference

24 August 2017

Juan M Bergua

4

1 reference

24 August 2017

Maria Jose Arcos

6

1 reference

24 August 2017

Maria Luisa Bengochea

7

1 reference

24 August 2017

Esther Duran

8

1 reference

24 August 2017

5 June 2011

1 reference

Cancer Immunology, Immunotherapy

24 August 2017

1 reference

24 August 2017

60

1 reference

24 August 2017

8

1 reference

24 August 2017

1195-1205

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1050-2

24 August 2017

0 references

cites work

Human NK cell education by inhibitory receptors for MHC class I.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

CD56 negative NK cells: origin, function, and role in chronic viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Line of attack: NK cell specificity and integration of signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The NKG2D receptor: immunobiology and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Effect of NKG2D ligand expression on host immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Immunity, ageing and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Promiscuity and the single receptor: NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

CD48: A co-stimulatory receptor of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Human natural killer cell development and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The function of natural killer cells: education, reminders and some good memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Natural killer-dendritic cell cross-talk in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Licensing of natural killer cells by host major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Functional role of human NK cell receptor 2B4 (CD244) isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Activated leukocyte cell adhesion molecule: a new paradox in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Natural killer cell education and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Are cancer and ageing different sides of the same coin? Conference on Cancer and Ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Soluble NKG2D ligands: prevalence, release, and functional impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Aging and Innate Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Adaptive immune features of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Continuous engagement of a self-specific activation receptor induces NK cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Identification of natural killer cell receptor phenotypes associated with leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NK cell receptors and their ligands in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Natural killer cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

NK cells and cancer immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1050-2

10.1007/S00262-011-1050-2

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference